1. The role of the U.S. Food and Drug Administration in device evaluation and monitoring;Diehl;Gastrointest Endosc,2010
2. United States Senate: Health, Education, Labor, and Pensions Committee. Preventable tragedies: superbugs and how ineffective monitoring of medical device safety fails patients. https://www.help.senate.gov/imo/media/doc/Duodenoscope%20Investigation%20FINAL%20Report.pdf. Accessed March 20, 2019.
3. US Food and Drug Administration (FDA). Infections associated with reprocessed duodenoscopes. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ReprocessingofReusableMedicalDevices/ucm454630.htm#meeting. Accessed March 20, 2019.
4. US Food and Drug Administration (FDA). Post-market surveillance orders (522) interactive website. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss.cfm?start_search=O#O. Accessed March 20, 2019.
5. US Food and Drug Administration (FDA). Brief summary of the gastroenterology and urology devices panel meeting, May 14-15, 2015. https://wayback.archive-it.org/7993/20170112083625/http:/www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Gastroenterology-UrologyDevicesPanel/UCM447407.pdf. Accessed March 20, 2019.